PNC Financial Services Group’s Dare Bioscience DARE Stock Holding History

PNC Financial Services Group’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-250	Closed	-$1.01K	–	4821
2024 Q2	$1.01K	Sell	250 -117	-32%	-$567	﹤0.01%	4424
2024 Q1	$2.16K	Hold	367	–	–	﹤0.01%	4178
2023 Q4	$1.36K	Hold	367	–	–	﹤0.01%	4257
2023 Q3	$2.03K	Hold	367	–	–	﹤0.01%	4243
2023 Q2	$4K	Hold	367	–	–	﹤0.01%	4170
2023 Q1	$4.58K	Hold	367	–	–	﹤0.01%	4067
2022 Q4	$3.65K	Hold	367	–	–	﹤0.01%	4097
2022 Q3	$4K	Buy	367 +84	+30%	+$1.15K	﹤0.01%	4010
2022 Q2	$4K	Buy	283 +83	+42%	+$1.25K	﹤0.01%	4041
2022 Q1	$4K	Hold	200	–	–	﹤0.01%	4047
2021 Q4	$5K	Buy	200 +83	+71%	+$1.71K	﹤0.01%	3968
2021 Q3	$2K	Buy	+117	New	+$2.31K	﹤0.01%	4096
2018 Q2	–	Sell	-4	Closed	–	–	4154
2018 Q1	$0	Buy	+4	New	+$81	﹤0.01%	4188

Other funds holding DARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FFS

Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PNC Financial Services Group's DARE Position: Q3 2024 in Review

PNC Financial Services Group sold out of Dare Bioscience (DARE) in Q3 2024, closing a stake of 250 shares — an estimated $1.01K sold.

PNC Financial Services Group first reported a position in DARE in Q1 2018 and held it in 13 quarters. The position peaked at $5K in Q4 2021. 22 funds tracked by Wall St. Rank hold DARE as of Q3 2024.

PNC Financial Services Group reported no remaining Dare Bioscience position as of Q3 2024 after selling out during the quarter.
PNC Financial Services Group sold 250 Dare Bioscience shares in Q3 2024, an estimated $1.01K.
PNC Financial Services Group first reported a position in Dare Bioscience in Q1 2018 and held it in 13 quarters.
PNC Financial Services Group's Dare Bioscience position peaked at $5K in Q4 2021.
22 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2024.

Based on PNC Financial Services Group's 13F filing for Q3 2024, filed 8 Nov 2024.